Inventor · disambiguated record
Daphne Hessels
Also filed as: HESSELS DAPHNE
7 granted patents·15 pending applications·34 citations·filing 2004–2023
83Inventor score
Files withMDXHEALTH RES B V6STICHTING KATHOLIEKE UNIV4HESSELS DAPHNE2MDXHEALTH SA2NOVIOGENDIX RES B V2
Top patents by PatentIndex Score
22 records- 0192US7960109B2mRNA ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancerSTICHTING KATHOLIEKE UNIV·Filed 2005·Granted Jun 14, 2011·20 cites·22 claims
- 0286US8257924B2mRNA ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancerHESSELS DAPHNE·Filed 2011·Granted Sep 4, 2012·8 cites·22 claims
- 0383US9096907B2Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIV·Filed 2013·Granted Aug 4, 2015·3 cites·21 claims
- 0481US9951390B2Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIV THE UNIV MEDICAL CENTRE NIJMEGEN·Filed 2016·Granted Apr 24, 2018·2 cites·20 claims
- 0578US10752957B2Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIVERSITEIT THE UNIV MEDICAL CENTRE NIJMEGEN·Filed 2018·Granted Aug 25, 2020·1 cites·19 claims
- 0673US2024076743A1Method for Predicting and Treating Clinically Significant Prostate CancerMDXHEALTH SA·Filed 2023·Application pending·0 cites
- 0767US11767563B2Method for predicting and treating clinically significant prostate cancerMDXHEALTH SA·Filed 2019·Granted Sep 26, 2023·0 cites·10 claims
- 0867US2020392588A1Prostate Cancer Prognostic Compositions and KitsSTICHTING KATHOLIEKE UNIV THE UNIV MEDICAL CENTRE NIJMEGEN·Filed 2020·Application pending·0 cites
- 0965US2009233285A1Specific method of prostate cancer detection based on pca3 gene, and kits thereforSTICHTING KATHOLIEKE UNIV·Filed 2008·Application pending·0 cites
- 1060US2015307948A1Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIV·Filed 2015·Application pending·0 cites
- 1159US2005164223A1Specific method of prostate cancer detection based on PCA3 gene and kits thereforUNIV MEDICAL CT NIJMEGEN·Filed 2004·Application pending·0 cites
- 1257US2021246515A1COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCERMDXHEALTH RES B V·Filed 2021·Application pending·0 cites
- 1357US2020165684A1COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCERMDXHEALTH RES B V·Filed 2019·Application pending·0 cites
- 1456US2012309006A1Specific method of prostate cancer detection based on pca3 gene, and kits thereforSCHALKEN JACK A·Filed 2012·Application pending·0 cites
- 1554US2012309007A1Prostate cancer prognostic compositions and kitsHESSELS DAPHNE·Filed 2012·Application pending·0 cites
- 1653US10329625B2Method for detecting DLX1 mRNA, HOXC6 mRNA, and KLK3 mRNA in a urine sample and predicting and treating clinically significant prostate cancerMDXHEALTH RES B V·Filed 2016·Granted Jun 25, 2019·0 cites·8 claims
- 1753US2012108453A1Molecular markers in prostate cancerSMIT FRANCISCUS PETRUS·Filed 2009·Application pending·0 cites
- 1851US2023151427A1Combinations of molecular markers with improved sensitivity and specificity for predicting and treating prostate cancerMDXHEALTH RES B V·Filed 2021·Application pending·0 cites
- 1945US2016194724A1Combinations of molecular markers with improved sensitivity and specificity for predicting and treating prostate cancerMDXHEALTH RES B V·Filed 2016·Application pending·0 cites
- 2044US2016017434A1Molecular markers in bladder cancerNOVIOGENDIX RES B V·Filed 2014·Application pending·0 cites
- 2143US2019284641A1Combinations of molecular markers with improved sensitivity and specificity for predicting and treating prostate cancerMDXHEALTH RES B V·Filed 2019·Application pending·0 cites
- 2241US2015017640A1Combinations of Molecular Markers in Prostate Cancer providing a Diagnostic Tool with Improved Sensitivity/SpecificityNOVIOGENDIX RES B V·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daphne Hessels files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →